Introduction: The study aimed to evaluate the in vitro antimicrobial activity of a new liposomal ocular spray containing the antiseptic Biosecur citrus extract (Oftasecur, OFFHEALTH, Florence, Italy) and its in vitro effects on cultured human corneal and conjunctival cells. Methods: Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of Oftasecur against Candida albicans and Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains, were determined. Human corneal and conjunctival epithelial cells in vitro were incubated for 10 and 30 min with Oftasecur or its components. The cytotoxicity was assessed through the release of cytoplasmic enzyme lactate dehydrogenase (LDH) into the medium; the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate the cell viability. Results: Oftasecur was active at dilutions ranging from 1:2 to 1:16 and it displayed bactericidal and fungicidal effect against all assayed microorganisms. Most of the reduction of Staphylococcus epidermidis vitality (65%) occurred within the first minute of exposure. The cytotoxicity of Oftasecur was similar to its vehicle, and the cell viability was significantly reduced only by Oftasecur in its undiluted form. Conversely, Biosecur induced a significant cytotoxicity in all the experiments. Conclusion: Oftasecur showed a rapid and wide-spectrum antibacterial activity, with an optimal in vitro tolerability profile.
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract / Rita Mencucci; Emilia Ghelardi; Francesco Celandroni; Costanza Mazzantini; Alessandra Vecchione; Domenico Edoardo Pellegrini-Giampietro; Eleonora Favuzza; Elisa Landucci. - In: OPHTHALMOLOGY AND THERAPY. - ISSN 2193-8245. - STAMPA. - 11:(2022), pp. 1067-1077. [10.1007/s40123-022-00492-0]
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract
Rita Mencucci
;Costanza Mazzantini;Domenico Edoardo Pellegrini-Giampietro;Eleonora Favuzza;Elisa Landucci
2022
Abstract
Introduction: The study aimed to evaluate the in vitro antimicrobial activity of a new liposomal ocular spray containing the antiseptic Biosecur citrus extract (Oftasecur, OFFHEALTH, Florence, Italy) and its in vitro effects on cultured human corneal and conjunctival cells. Methods: Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of Oftasecur against Candida albicans and Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains, were determined. Human corneal and conjunctival epithelial cells in vitro were incubated for 10 and 30 min with Oftasecur or its components. The cytotoxicity was assessed through the release of cytoplasmic enzyme lactate dehydrogenase (LDH) into the medium; the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate the cell viability. Results: Oftasecur was active at dilutions ranging from 1:2 to 1:16 and it displayed bactericidal and fungicidal effect against all assayed microorganisms. Most of the reduction of Staphylococcus epidermidis vitality (65%) occurred within the first minute of exposure. The cytotoxicity of Oftasecur was similar to its vehicle, and the cell viability was significantly reduced only by Oftasecur in its undiluted form. Conversely, Biosecur induced a significant cytotoxicity in all the experiments. Conclusion: Oftasecur showed a rapid and wide-spectrum antibacterial activity, with an optimal in vitro tolerability profile.File | Dimensione | Formato | |
---|---|---|---|
2022 Ophthalm Ther Mencucci.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.92 MB
Formato
Adobe PDF
|
1.92 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.